美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MRNA期權收益策略ETF-YieldMax

32.65

+1.474.71%

盤後：32.850.2000+0.61%19:59 EDT

成交量：25.03萬

成交額：820.63萬

市值：1.36億

市盈率：- -

高：33.70

開：31.19

低：30.76

收：31.18

52周最高：42.39

52周最低：13.60

股本：418.00萬

流通股本：418.00萬

量比：1.11

換手率：5.99%

股息：16.18

股息率：49.56%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

Moderna第二季度每股收益-1.97美元，優於IBES預期的-2.08美元

Moderna(MRNA.US)盤前跌5.7%二季度營收略低於預期。

Moderna宣佈：mRNA-1403 III期中期分析未達早期成功統計標準，正籌備新增隊列招募

Moderna預期其第五款產品Mflusiva將於8月5日迎來PDUFA審批關鍵節點

今日關注要點——7月31日（星期五）

默克、惠康與一家全球衞生組織合作，共同研製埃博拉疫苗以用於臨床試驗

總部位於荷蘭阿姆斯特丹的全球生物製藥公司 ARGENX將以每股77美元的現金收購FORTE BIOSCIENCES。

數據簡報-邦迪布吉奧埃博拉病毒：正在研發哪些疫苗和治療方法

安永：至2028年全球前25大醫藥企業存在千億美元增長缺口

生物技術專家希望美國食品藥品監督管理局（FDA）的藥物評審基於科學，而非政治

莫德納稱，CureVac因就新冠疫苗專利提起訴訟而違反了協議

Moderna宣佈首例患者接受針對實體瘤的研究性腫瘤靶向癌症抗原療法一期臨床試驗

賽諾菲就新冠疫苗技術起訴輝瑞和莫德納

免疫疾病生物製藥公司Attovia(ATTO.US)申請在美上市擬募資1億美元

免疫疾病生物製藥公司Attovia(ATTO.US)申請在美上市擬募資1億美元

免疫疾病生物製藥公司Attovia(ATTO.US)申請在美上市擬募資1億美元

傑富瑞：將Moderna(MRNA.US)目標價從53美元上調至60美元。

重温-美國股市：標普500指數接近紀錄高位，投資者目光轉向財報季

1個月上漲25%後，美國生物醫藥板塊周五重挫

华尔街见闻

ETF日報｜2倍做多Cerebras Systems ETF漲近17%；2倍做多Meta ETF漲12%；材料與地產帶動行業走強

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/MRNY/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MRNY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNY\",,,,,undefined,":{"symbol":"MRNY","market":"US","secType":"STK","nameCN":"MRNA期權收益策略ETF-YieldMax","latestPrice":32.65,"timestamp":1789156800000,"preClose":31.18,"halted":0,"volume":250332,"hourTrading":{"tag":"盘后","latestPrice":32.85,"preClose":32.65,"latestTime":"19:59 EDT","volume":1216,"amount":39789.4598,"timestamp":1789171191022,"change":0.2,"changeRate":0.006126,"amplitude":0.020521},"delay":0,"changeRate":0.047145606157793424,"floatShares":4179974,"shares":4179974,"eps":0,"marketStatus":"休市中","change":1.47,"latestTime":"09-11 16:00:00 EDT","open":31.19,"high":33.6999,"low":30.7601,"amount":8206288.497839999,"amplitude":0.094285,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":31.18,"sharesOutstanding":6479974,"nav":31.16,"aum":135700989.84,"dividendRate":0.495559,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":31.2999,"preClose":31.18,"latestTime":"09:28 EDT","volume":4365,"amount":135981.277965,"timestamp":1789133288924,"change":0.1199,"changeRate":0.003845,"amplitude":0.020205},"postHourTrading":{"tag":"盘后","latestPrice":32.85,"preClose":32.65,"latestTime":"19:59 EDT","volume":1216,"amount":39789.4598,"timestamp":1789171191022,"change":0.2,"changeRate":0.006126,"amplitude":0.020521},"volumeRatio":1.1071728366970954,"impliedVol":0.5408,"impliedVolPercentile":0.664},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNY\",,,,,undefined,":{"symbol":"MRNY","floatShares":4179974,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.1071728366970954,"shares":4179974,"dividePrice":16.18,"high":33.6999,"amplitude":0.094285,"preClose":31.18,"low":30.7601,"week52Low":13.6,"pbRate":"--","week52High":42.39,"institutionHeld":0,"latestPrice":32.65,"eps":0,"divideRate":0.495559,"volume":250332,"delay":0,"ttmEps":0,"open":31.19,"prevYearClose":14.7,"prevWeekClose":33.47,"prevMonthClose":33.25,"prevQuarterClose":19.33,"fiveDayClose":33.9,"twentyDayClose":15.73,"sixtyDayClose":16.72},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRNY\",params:#limit:5,,,undefined,":[{"date":"2026-09-10","symbol":"MRNY","amount":0.642,"announcedDate":"2026-09-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-10","defaultRemindTime":1789047000000,"name":"MRNA期权收益策略ETF-YieldMax","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-11","payableDate":"2026-09-10","currency":"USD","dateTimestamp":1789012800000,"payDate":"2026-09-11"},{"date":"2026-09-03","symbol":"MRNY","amount":0.6373,"announcedDate":"2026-09-02","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-03","defaultRemindTime":1788442200000,"name":"MRNA期权收益策略ETF-YieldMax","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-04","payableDate":"2026-09-03","currency":"USD","dateTimestamp":1788408000000,"payDate":"2026-09-04"},{"date":"2026-08-27","symbol":"MRNY","amount":0.8925,"announcedDate":"2026-08-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-27","defaultRemindTime":1787837400000,"name":"MRNA期权收益策略ETF-YieldMax","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-28","payableDate":"2026-08-27","currency":"USD","dateTimestamp":1787803200000,"payDate":"2026-08-28"},{"date":"2026-08-20","symbol":"MRNY","amount":0.2261,"announcedDate":"2026-08-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-20","defaultRemindTime":1787232600000,"name":"MRNA期权收益策略ETF-YieldMax","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-21","payableDate":"2026-08-20","currency":"USD","dateTimestamp":1787198400000,"payDate":"2026-08-21"},{"date":"2026-08-13","symbol":"MRNY","amount":0.2216,"announcedDate":"2026-08-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-13","defaultRemindTime":1786627800000,"name":"MRNA期权收益策略ETF-YieldMax","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-14","payableDate":"2026-08-13","currency":"USD","dateTimestamp":1786593600000,"payDate":"2026-08-14"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRNY\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-07","recordDate":"2023-12-08","paymentDate":"2023-12-13","value":0.413,"currency":"USD"},{"executeDate":"2024-01-05","recordDate":"2024-01-08","paymentDate":"2024-01-09","value":2.6542,"currency":"USD"},{"executeDate":"2024-02-07","recordDate":"2024-02-08","paymentDate":"2024-02-09","value":0.5944,"currency":"USD"},{"executeDate":"2024-03-06","recordDate":"2024-03-07","paymentDate":"2024-03-08","value":1.131,"currency":"USD"},{"executeDate":"2024-04-04","recordDate":"2024-04-05","paymentDate":"2024-04-08","value":0.7832,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MRNY\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MRNY\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1191369993","title":"Moderna第二季度每股收益-1.97美元，優於IBES預期的-2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191369993","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191369993?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:16","pubTimestamp":1785496607,"startTime":"0","endTime":"0","summary":"Moderna公布的2026年第二季度财报显示，公司净亏损达8亿美元，折合每股收益为-1.97美元。这一数字，相较于市场通过IBES调查所预估的-2.08美元，表现略胜一筹。季度数据源自该公司于7月31日发布的官方财务报告。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","LGHT","BK4585","BK4532","BK4139","BK4534","IDNA","BK4548","MRNY","BK4568","BK4551","BK4588","GNOM","MRNA","MRNX","BK4501","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655368109","title":"Moderna(MRNA.US)盤前跌5.7%二季度營收略低於預期。","url":"https://stock-news.laohu8.com/highlight/detail?id=2655368109","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655368109?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:04","pubTimestamp":1785495856,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","LGHT","BK4532","BK4551","BK4568","GNOM","BK4533","BK4548","BK4534","BK4588","WDNA","IDNA","BK4501","MRNA","MRNY","MRNX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113092299","title":"Moderna宣佈：mRNA-1403 III期中期分析未達早期成功統計標準，正籌備新增隊列招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1113092299","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113092299?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:02","pubTimestamp":1785495775,"startTime":"0","endTime":"0","summary":"Moderna公司披露，其mRNA-1403候选药物在III期临床试验的中期分析中，并未达到预设的早期成功统计阈值。这一结果意味着，该药物未能展现出足以支撑其提前获批的显著疗效。尽管如此，公司并未止步于此。Moderna目前正紧锣密鼓地筹备，计划增设一个额外的受试者队列，以期进一步评估该药物的潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","IDNA","MRNX","BK4588","MRNY","BK4139","WDNA","BK4585","BK4568","BK4548","BK4534","BK4532","BK4551","GNOM","LGHT","MRNA","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145717315","title":"Moderna預期其第五款產品Mflusiva將於8月5日迎來PDUFA審批關鍵節點","url":"https://stock-news.laohu8.com/highlight/detail?id=1145717315","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145717315?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:02","pubTimestamp":1785495774,"startTime":"0","endTime":"0","summary":"Moderna公司近日释放积极信号，预计其第五款产品——针对Mflusiva的疗法，有望在今年8月5日的PDUFA日期获得监管批准。这一日期标志着FDA对该药物申请的最终审查期限，若顺利通关，将成为Moderna产品管线中的又一重要里程碑。目前，市场正密切关注这一审批进程，期待它为生物医药领域注入新动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNOM","BK4585","BK4533","IDNA","MRNX","LGHT","BK4532","MRNA","BK4551","BK4568","MRNY","WDNA","BK4548","BK4534","BK4588","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655800659","title":"今日關注要點——7月31日（星期五）","url":"https://stock-news.laohu8.com/highlight/detail?id=2655800659","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655800659?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 02:30","pubTimestamp":1785436236,"startTime":"0","endTime":"0","summary":"今日关注要点——7月31日（星期五）《今日要闻》是一份通过电子邮件和PDF形式发布的刊物，内容涵盖当日主要新闻、事件、分析及其他专题报导。消费品制造商Church & Dwight则预计受需求疲软影响，第二季度营收将出现下滑。投资者将关注其新冠疫苗的销售情况，以及全年利润预期的任何调整。在加拿大经济方面，加拿大统计局计划发布5月份国内生产总值数据，预计将增长0.2%，此前为增长0.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL4T43W2IR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2430703095.HKD","BK4592","LU1066053197.SGD","LBO","DRLL","XOM","IXC","MRNX","LU1496350171.SGD","AAUM","WDNA","IE00B1XK9C88.USD","LU0971096721.USD","XLE","LU0690374615.EUR","LU0878866978.SGD","TEXU","WEEI","ARES","IE00BLSP4452.SGD","LGHT","GNOM","CL","MRNY","SG9999002224.SGD","GPZ","IDNA","FTXN","GXPE","BEN","OILT","IYE","BK4581","IGE","LU1074936037.SGD","PRVT","LU0266013472.USD","CVX","CHD","XOMZ","LU2430703251.USD","XOMX","FENY","DIG","VDE","XOMO","LU2237438978.USD","MRNA","TRUN","ERX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655842772","title":"默克、惠康與一家全球衞生組織合作，共同研製埃博拉疫苗以用於臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2655842772","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655842772?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 13:03","pubTimestamp":1785387832,"startTime":"0","endTime":"0","summary":"默克与惠康基金会的合作将推动国际艾滋病疫苗倡议组织研发的单剂量疫苗的生产，世界卫生组织今年5月曾将其列为最具前景的候选疫苗。希勒曼公司将利用IAVI提供的起始原料，生产可用于早期临床试验的成品疫苗剂量。默克公司传染病与疫苗研发负责人塔里特·穆科帕迪亚在接受采访时表示，疫苗剂量有望在今年年底前准备就绪，用于临床试验。穆科帕迪亚表示，希勒曼实验室具备生产数万剂疫苗的能力，这应足以满足试验需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL4S43W0CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772840.SGD","LU1116320737.USD","LU2491050071.SGD","BK4548","BK4007","LU1035773651.USD","GDOC","IE00BJT1NW94.SGD","LU0266013472.USD","LU2106854487.HKD","LU1093756325.SGD","SG9999002232.USD","LU0868494708.USD","LU0965509283.SGD","LU2361044949.HKD","SG9999001176.USD","LU0320765489.SGD","BK4550","IE00B4R5TH58.HKD","LU0868494617.USD","LU2023250843.SGD","LU1061106388.HKD","TRUH","IE00BBT3K403.USD","LU0980610538.SGD","MRNX","LU0320765646.SGD","LU0070302665.USD","LU1571399168.USD","LU1917777945.USD","LU1162221912.USD","LU0477156953.USD","BK4533","BK4559","LU0985320562.USD","FHLC","LU0265550359.USD","LU0130102774.USD","LU1430594728.SGD","LU2125154778.USD","LU1023059063.AUD","SG9999014575.USD","LU2089984988.USD","LU1066051498.USD","SG9999015358.SGD","IDNA","LU0203347892.USD","LU2461242641.AUD","LU1941712264.USD","LU0648001328.SGD","LU0208291251.USD","LU1989771016.USD","LU1929549753.HKD","LU1069347547.HKD","LU0130517989.USD","LU1066053197.SGD","LU1585245621.USD","SG9999014542.SGD","BK4568","WDNA","LU0942090050.USD","LU1037948541.HKD","IYH","LU1989772923.USD","LU1934455863.HKD","HRTS","LU0211331839.USD","IE00BFTCPJ56.SGD","MRK","SG9999013999.USD","IE00B2B36J28.USD","PPH","LU0432979614.USD","LU2468319806.SGD","LU2023250504.SGD","PAWZ","BK4534","IXJ","LU2125909593.SGD","LU0058720904.USD","BK4139","LU2361045086.USD","IE00BLSP4452.SGD","LU2357627491.SGD","LU0965509101.SGD","BK4532","SGXZ57979304.SGD","LU0122379950.USD","LU2361044865.SGD","IE00BN8TJ469.HKD","XLV","LU2112291526.USD","IE00BLSP4239.USD","MRNA","LU0289739699.SGD","LU2125909247.SGD","JDOC","LU0203345920.USD","IE00BSNM7G36.USD","LU1934455277.USD","BK4588","FTXH","IE0002141913.USD","GNOM","LU1923622614.USD","LU0238689110.USD","BK4585","LU1941712348.USD","BK4501","LU1093756168.USD","RXL","IE00B1BXHZ80.USD","LU0234572021.USD","LU1066051811.HKD","SG9999001176.SGD","LU1699723380.USD","SG9999001440.SGD","SG9999015341.SGD","LU0124676726.USD","BK4551","MRNY","LU0689626769.HKD","LU0965509010.AUD","IE0009355771.USD","IE000M9KFDE8.USD","LU0965508806.USD","LU1057294990.SGD","LU0098860793.USD","LU1974910355.USD","LU1066051225.USD","LU1201861249.SGD","LU1291159041.SGD","LGHT","LU0006306889.USD","LU0265550946.USD","LU1116320901.HKD","VHT","BMED","LU2125154935.USD","LU1934455194.USD","SG9999014567.USD","IE00BJJMRZ35.SGD","SG9999002224.SGD","LU2491049909.HKD","LU2491050154.USD","LU0106261372.USD","LU1037948897.HKD","SG9999014559.SGD","BK4516","LU0859254822.USD","LU2433249047.HKD","LU2324357040.USD","LU0861579265.USD","IHE","LU1983299246.USD","LU2360032135.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654091684","title":"總部位於荷蘭阿姆斯特丹的全球生物製藥公司 ARGENX將以每股77美元的現金收購FORTE BIOSCIENCES。","url":"https://stock-news.laohu8.com/highlight/detail?id=2654091684","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654091684?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 13:03","pubTimestamp":1785128639,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","MRNX","UDN","MRNY","UUP","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653618768","title":"數據簡報-邦迪布吉奧埃博拉病毒：正在研發哪些疫苗和治療方法","url":"https://stock-news.laohu8.com/highlight/detail?id=2653618768","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653618768?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 20:52","pubTimestamp":1784724736,"startTime":"0","endTime":"0","summary":"数据简报-邦迪布吉奥埃博拉病毒：正在研发哪些疫苗和治疗方法更新疫情数据，补充临床试验进展及诊断检测详情Mariam Sunny/Jennifer Rigby路透7月22日-全球卫生部门正争分夺秒地寻找医疗方案，以遏制刚果民主共和国东部由邦迪布吉奥  埃博拉病毒株引发的疫情。与更常见的扎伊尔毒株不同，目前尚无针对邦迪布吉奥毒株的获批疫苗或治疗方法。据该公司称，实验室研究表明该药物对邦迪布吉奥埃博拉病毒具有活性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL4T43O1A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0980610538.SGD","LU0345777659.USD","LU1814569148.SGD","LU0708994859.HKD","LU1015430645.USD","BK0239","FHLC","LU0477156953.USD","IE00BKVL7J92.USD","LU0827474353.SGD","LU1153585028.USD","LU0964806797.USD","LU0047473722.EUR","LU1066051811.HKD","SG9999015358.SGD","BK4007","LU0053666078.USD","GDOC","LU0289739699.SGD","LU0238689110.USD","MRNX","SG9999001440.SGD","LU1674673428.USD","LU0792757196.USD","MRNY","SG9999001176.USD","LU0857590862.USD","LU1267930573.SGD","GILD","IE00BSNM7G36.USD","LU0234572021.USD","LU0203345920.USD","LU0345777147.USD","LU1116320737.USD","LU2324357040.USD","LU0965509010.AUD","IE0034235188.USD","LU1035773651.USD","LU0310799852.SGD","LU0648001328.SGD","LU0124676726.USD","LU0960981461.USD","LU1481599808.USD","BK4566","BK4583","LU2461242641.AUD","BK4533","MEDI","LU1934455194.USD","LU1674673691.USD","LU2539964713.USD","IE00BKPKM643.USD","BK4551","LU0887340254.USD","LU1267930813.SGD","LU0211331839.USD","SG9999015341.SGD","LU1291159041.SGD","LU1093756325.SGD","LU0823399737.USD","SG9999015952.SGD","03165","LU1003076772.USD","LU2279689827.SGD","LU1003077747.HKD","IBB","LU0757432116.USD","LU0689626769.HKD","IE0009355771.USD","LU0972486137.USD","LU1064927863.SGD","LU0208291251.USD","BIB","LU1019632923.USD","LU1119994496.HKD","LU1267930227.SGD","BK4548","RXL","LU0526926950.USD","BK4139","LU1917777945.USD","LU2108987350.USD","LU2360032135.SGD","LU1487256676.USD","LU2112291526.USD","IYH","LU1116320901.HKD","IE00BJT1NW94.SGD","LU1989771016.USD","LU2114397693.USD","LU1084165304.USD","BBH","LU1778281490.HKD","SG9999002232.USD","BK4198","OSUR","LU0109394709.USD","LU1496350502.SGD","JDOC","IXJ","LU1355424745.HKD","LU0661504455.SGD","LU0390134368.USD","IHE","LU1941712264.USD","TRUH","IE00B19Z3581.USD","LU0496365809.HKD","LU1430594728.SGD","LU0882574055.USD","LU2237438978.USD","IE00BN8TJ469.HKD","BK4534","LU0211328371.USD","GNOM","LU1571399168.USD","LU1496350171.SGD","LU2087621335.USD","LU0949170426.SGD","IE00BLSP4239.USD","LU1196032939.SGD","LU0784383803.USD","LU1983299246.USD","LU1267930490.SGD","LU2237443622.USD","LU2355687059.USD","LU0432979614.USD","LU0997586432.USD","LU1323610961.USD","LU1829250122.USD","LU2491049909.HKD","BK4588","LU0861579265.USD","LU1078025761.USD","LU2362541513.USD","LU2491050154.USD","LU1066051498.USD","LU2125154778.USD","LU2089984988.USD","LU0106261372.USD","LU0784384876.USD","LU1046234339.USD","PPH","LU0029864427.USD","LU0976567544.SGD","LU0823434740.USD","BK5011","LU2293690249.USD","LU0784385170.HKD","LU1880407132.USD","LU0557290698.USD","LU0889565916.HKD","REGN","LU0320765489.SGD","SG9999015945.SGD","LU2237443895.HKD","LU0114720955.EUR","LU0889565080.SGD","LU1989772923.USD","LU2361045086.USD","LU0171276677.USD","LU1162221912.USD","BK4585","LU1923622614.USD","LU1880407215.USD","LU0965509283.SGD","BK4578","LU0098860793.USD","LU1037948897.HKD","SG9999014559.SGD","LU0965509101.SGD","LU2237443978.SGD","LU0499090636.EUR","LU1481600234.SGD","LU1170363599.USD","WDNA","SG9999015986.USD","LU2023250504.SGD","LU0889566641.SGD","LU1585245621.USD","LU2491050071.SGD","LU1989772840.SGD","LU1104425308.USD","LU0545039389.USD","LU0077335932.USD","SG9999014575.USD","BK4516","LU0211326755.USD","LU1699723380.USD","SG9999001176.SGD","IE00BJJMRZ35.SGD","LU2133065610.SGD","LU3187612489.SGD","SG9999013999.USD","LGHT","LU1066051225.USD","LU0949170772.SGD","TMED","LU0784385840.USD","LU0211326839.USD","IE00BZ1G4Q59.USD","LU2293690082.USD","IE00BFTCPJ56.SGD","LU0997586515.USD","LU0859254822.USD","BK4501","MRNA","IDNA","LU0070302665.USD","LU0738911758.USD","LU0234570918.USD","FTXH","LU2361044865.SGD","IE00B2B36J28.USD","LU0868494617.USD","LU1301847155.USD","LU0265550946.USD","LU1066053197.SGD","TBXU","LU1974910355.USD","LU0265550359.USD","LU0920840948.USD","LU1037948541.HKD","SG9999002224.SGD","LU2125909593.SGD","LU2237443549.SGD","LU0985320562.USD","LU1201861249.SGD","IE0002270589.USD","LU2089283258.USD","LU0171293334.USD","LU1051770623.HKD","SG9999014542.SGD","LU2361044949.HKD","LU0058720904.USD","LU0823434583.USD","LU0823416689.USD","HRTS","LU0963555726.SGD","LU1934455277.USD","LU0211327993.USD","IE00BBT3K403.USD","BK4568","LU0310800379.SGD","LU0868494708.USD","LU0203347892.USD","IE00B19Z3B42.SGD","LU0052756011.USD","LU0942090050.USD","IBBQ","IE00BLSP4452.SGD","LU2468319806.SGD","LU0130102774.USD","LU1941712348.USD","LU0128525929.USD","LU0128525689.USD","BK4550","LU1153584641.USD","XLV","LU0266013472.USD","IE00B1BXHZ80.USD","LU1863844749.USD","LU1934455863.HKD","LU2023250843.SGD","LU0158827948.USD","LU0575583348.USD","LU0320765992.SGD","LU2125154935.USD","LU2106854487.HKD","LU1057294990.SGD","LU2357627491.SGD","688317","LU2237443382.USD","LU0006306889.USD","LU0965508806.USD","LU0122379950.USD","LU2125909247.SGD","LU0640478417.SGD","BK4559","LU1273509221.SGD","AZN.UK","VHT","LU2433249047.HKD","LU0310800965.SGD","IE00B3T34201.USD","SG9999015978.USD","LU0320765646.SGD","SGXZ57979304.SGD","BK4532","LU2237443465.HKD","MRK","LU1929549753.HKD","LU0969580561.USD","LU0047473722.SGD","IE00B4R5TH58.HKD","LU1093756168.USD","IE000M9KFDE8.USD","LU0553294199.USD","LU2089284900.SGD","LU0130517989.USD","LU0011850046.USD","LU2091194634.USD","LU1023059063.AUD","LU2023251221.USD","BMED","SG9999014567.USD","IE0002141913.USD","LU2362541273.HKD","LU1863844665.USD","LU0957799991.USD","LU1019634622.SGD","LU2362540622.SGD","LU1261432733.SGD","LU0920783379.SGD","LU1061106388.HKD","LU1069347547.HKD","PAWZ","IE00B7SZLL34.SGD","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653752990","title":"安永：至2028年全球前25大醫藥企業存在千億美元增長缺口","url":"https://stock-news.laohu8.com/highlight/detail?id=2653752990","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653752990?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 19:23","pubTimestamp":1784719424,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BBP","IBBQ","MRNX","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653759874","title":"生物技術專家希望美國食品藥品監督管理局（FDA）的藥物評審基於科學，而非政治","url":"https://stock-news.laohu8.com/highlight/detail?id=2653759874","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653759874?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 18:01","pubTimestamp":1784714498,"startTime":"0","endTime":"0","summary":"生物技术专家希望美国食品药品监督管理局的药物评审基于科学，而非政治生物技术投资者希望监管具有可预测性马斯克的DOGE导致FDA裁减了3,000多个职位FDA现获准招聘2,200名员工特朗普政府正在考虑三位FDA局长候选人Deena Beasley路透7月22日-生物技术专家和行业高管认为，去年曾遭受裁员冲击的美国食品药品监督管理局计划招聘数千名员工并更新临床试验标准，这一举措令人鼓舞，但他们希望获得保证，确保政治因素不会干预该机构的药物审查流程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL4T43O0TL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX","NKTX","BK4585","GNOM","BK4551","BK4501","WDNA","MRNA","BK4568","BK4505","BK4588","BK4139","BK4532","LGHT","IDNA","BK4548","BK4534","MRNY","BK4533","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652212525","title":"莫德納稱，CureVac因就新冠疫苗專利提起訴訟而違反了協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2652212525","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652212525?lang=zh_tw&edition=fundamental","pubTime":"2026-07-20 23:37","pubTimestamp":1784561845,"startTime":"0","endTime":"0","summary":"莫德纳称，CureVac因就新冠疫苗专利提起诉讼而违反了协议Blake Brittain路透7月20日-莫德纳针对生物技术公司库尔瓦克就其畅销的新冠疫苗在特拉华州联邦法院提起的专利侵权诉讼进行了反诉，称该诉讼违反了双方之间的协议。莫德纳在周五提交的文件中称这两起诉讼均“毫无依据”。该证人此前曾在另一桩新冠疫苗专利案件中为莫德纳作证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nL4T43M13V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306806265.USD","LU1057294990.SGD","LU1894683348.USD","BK4551","BK4501","BK4533","SG9999003800.SGD","LU1883839398.USD","LU0456855351.SGD","IE00BLSP4239.USD","LU1066051498.USD","MRNY","LU0170899867.USD","BK4535","LU0321505868.SGD","LU0306807586.USD","SGXZ57979304.SGD","LU0058720904.USD","BK4532","BK4550","IE00B3T34201.USD","WDNA","LU1066053197.SGD","SG9999001176.SGD","IE00BBT3K403.USD","LU0868494617.USD","BK4548","LU2596442595.SGD","OZEM","LU0122379950.USD","LGHT","LU0225284248.USD","LU0225771236.USD","SG9999001176.USD","SG9999002224.SGD","SG9999013999.USD","BK4534","MRNA","MRNX","BK4581","IE000M9KFDE8.USD","BK4592","LU0321505439.SGD","PFE","IDNA","SG9999011175.SGD","IE00B19Z3B42.SGD","BK4585","BNTX","LU0289739699.SGD","IE00BLSP4452.SGD","LU0234572021.USD","BK4139","LU0985481810.HKD","LU1023059063.AUD","BK4599","GNOM","IE0002270589.USD","LU1894683264.USD","BK4568","BK4588","IE00B19Z3581.USD","SG9999002232.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107107295","title":"Moderna宣佈首例患者接受針對實體瘤的研究性腫瘤靶向癌症抗原療法一期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1107107295","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107107295?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 19:42","pubTimestamp":1784202143,"startTime":"0","endTime":"0","summary":"Moderna, Inc.宣布，其研究性肿瘤靶向癌症抗原疗法在针对实体瘤的一期临床试验中，已为首例患者完成给药。该试验旨在评估该疗法的安全性与初步疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","BK4139","BK4501","BK4532","MRNA","GNOM","BK4585","BK4568","IDNA","BK4551","BK4533","BK4534","LGHT","MRNX","BK4548","MRNY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651462903","title":"賽諾菲就新冠疫苗技術起訴輝瑞和莫德納","url":"https://stock-news.laohu8.com/highlight/detail?id=2651462903","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651462903?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 23:57","pubTimestamp":1784131036,"startTime":"0","endTime":"0","summary":"赛诺菲就新冠疫苗技术起诉辉瑞和莫德纳Blake Brittain路透7月15日-赛诺菲SASY.PA已起诉辉瑞PFE.N和莫德纳MRNA.O，指控这两家公司的新冠疫苗侵犯了这家法国制药公司的多项专利。赛诺菲  于周二在新泽西州联邦法院提起的两起诉讼  指控称，这些畅销疫苗侵犯了该公司在信使核糖核酸技术方面的专利权。周三，辉瑞和莫德纳的发言人未立即回应就赛诺菲新诉讼置评的请求。莫德纳于2022年以专利侵权为由起诉辉瑞 ，该案目前仍在审理中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nL4S43H1KJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","IE00B3T34201.USD","LU1023059063.AUD","BK4585","SG9999001176.SGD","LU1894683348.USD","IE0002270589.USD","BK4581","BK4550","IE00B19Z3581.USD","LU0306806265.USD","GNOM","BK4551","SG9999002232.USD","SNY","BK4501","OZEM","LU0289739699.SGD","LU1883839398.USD","MRNA","BK4568","SG9999013999.USD","WDNA","BK4588","BK4532","BK4139","LU0456855351.SGD","SGXZ57979304.SGD","LU0306807586.USD","LU1066051498.USD","LU2596442595.SGD","SG9999002224.SGD","LGHT","LU1066053197.SGD","LU0985481810.HKD","IDNA","BK4548","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0321505868.SGD","LU0868494617.USD","LU0170899867.USD","LU1057294990.SGD","SG9999001176.USD","LU0225771236.USD","SG9999011175.SGD","LU0058720904.USD","BK4007","IE00BLSP4452.SGD","PFE","LU1894683264.USD","BK4534","IE00BFXG1179.USD","LU0321505439.SGD","MRNY","IE00BLSP4239.USD","LU0234572021.USD","IE000M9KFDE8.USD","BK4592","LU0122379950.USD","BK4599","SG9999003800.SGD","BK4533","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651774435","title":"免疫疾病生物製藥公司Attovia(ATTO.US)申請在美上市 擬募資1億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651774435","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651774435?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 11:17","pubTimestamp":1784085422,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，临床阶段生物制药公司Attovia Therapeutics已提交首次公开募股申请，计划募集最多1亿美元资金。该公司计划在纳斯达克上市，股票代码为“ATTO”。　　据悉，Attovia利用其ATTOBODY平台开发用于治疗免疫介导性疾病的生物制剂。Alamar于2023年设立Attovia作为独立公司，以便自身专注于蛋白质组学和疾病检测业务，目前仍是Attovia的重要股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260715/32307966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["MRNY","MRNX","IPOS","BBP","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651435511","title":"免疫疾病生物製藥公司Attovia(ATTO.US)申請在美上市 擬募資1億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651435511","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651435511?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 10:45","pubTimestamp":1784083531,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，临床阶段生物制药公司Attovia Therapeutics已提交首次公开募股申请，计划募集最多1亿美元资金。据悉，Attovia利用其ATTOBODY平台开发用于治疗免疫介导性疾病的生物制剂。自通过IPO融资2.2亿美元以来，Alamar股价已上涨近60%。Alamar于2023年设立Attovia作为独立公司，以便自身专注于蛋白质组学和疾病检测业务，目前仍是Attovia的重要股东。Attovia的核心候选药物ATTO-1310针对白细胞介素-31，目前已完成针对健康志愿者以及患有慢性瘙痒症和特应性皮炎患者的Ⅰ期临床试验给药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1467668.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","MRNX","BBP","MRNY","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651435505","title":"免疫疾病生物製藥公司Attovia(ATTO.US)申請在美上市 擬募資1億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651435505","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651435505?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 10:45","pubTimestamp":1784083531,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","BBP","MRNX","MRNY","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651160208","title":"傑富瑞：將Moderna(MRNA.US)目標價從53美元上調至60美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2651160208","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651160208?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 11:55","pubTimestamp":1783914940,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","IDNA","UUP","BK4532","BK4568","BK4588","UDN","LGHT","BK4551","BK4534","BK4533","WDNA","BK4501","BK4139","GNOM","MRNX","MRNA","MRNY","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651161841","title":"重温-美國股市：標普500指數接近紀錄高位，投資者目光轉向財報季","url":"https://stock-news.laohu8.com/highlight/detail?id=2651161841","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651161841?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 07:30","pubTimestamp":1783899000,"startTime":"0","endTime":"0","summary":"本周美国和伊朗之间的袭击事件令市场再次担心，能源价格高企可能推升通胀，并迫使美联储加息。美国大型银行下周将拉开第二季度财报季序幕。得益于企业盈利预估上调，标普500指数目前的预期市盈率约为20倍，低于5月下旬的21倍，尽管该指标股指已处于纪录高位附近。标普500指数上涨0.42%，收于7,575.39点，较6月2日创下的纪录收盘高位仍低0.45%。本周，标普500指数上涨1.2%，纳指攀升1.7%，道指下跌0.5%。标普500指数涨跌股家数比为2.1:1。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260712:nL6S43C14Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XDAT","FBL","LU1035775433.USD","FBY","VOX","GNOM","LU2746668461.USD","FCOM","JETS","LTL","LU0784383803.USD","OGIG","SKHYV","LU0265550359.USD","LU1791710582.SGD","METU","LU0348723411.USD","LU1235294995.USD","FBYY","LU0889565833.HKD","NULC","XLC","LU0949170772.SGD","LU0310799852.SGD","METD","DAL","MRNA","BK4548","LU2458330169.SGD","LU2756315664.SGD","META","LU2133065610.SGD","LU0724617625.USD","RSPC","LU0738911758.USD","LGHT","METV","MRNX","LU2462591350.SGD","SKHY","LU0823421416.USD","METW","WDNA","BK4139","SOCL","LU2242650005.HKD","MRNY","LU0786609619.USD","LU2487616109.SGD","IDNA","LU2322448791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650155620","title":"1個月上漲25%後，美國生物醫藥板塊周五重挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2650155620","media":"华尔街见闻","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650155620?lang=zh_tw&edition=fundamental","pubTime":"2026-07-11 15:10","pubTimestamp":1783753844,"startTime":"0","endTime":"0","summary":"美股生物医药板块因集中获利了结引发急跌，高贝塔代表性ETF（XBI）单日大跌4%。Moderna、ImmunityBio等年内暴涨股在无基本面利空的情况下回撤8%~11%，资金呈现从高风险小盘股向强防御大市值药企跨板块结构性轮动。","market":"nz","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3776698","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"1个月上涨25%后，美国生物医药板块周五重挫","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLYX","BK4585","BK4588","LLYZ","XBI","ELIL","MRNY","161726","MRNA","LLII","MRNX","IBRX","LLY","BK4581","ELIS"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1133823051","title":"ETF日報｜2倍做多Cerebras Systems ETF漲近17%；2倍做多Meta ETF漲12%；材料與地產帶動行業走強","url":"https://stock-news.laohu8.com/highlight/detail?id=1133823051","media":"ETF追踪","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133823051?lang=zh_tw&edition=fundamental","pubTime":"2026-07-11 06:02","pubTimestamp":1783720938,"startTime":"0","endTime":"0","summary":"美股ETF涨幅Top5$2倍做多CBRS ETF-Leverage Shares$上涨16.78%。该产品两倍做多AI芯片公司$Cerebras Systems$，因底层公司股价上涨，杠杆机制放大当日涨幅。该产品两倍做多Cerebras Systems，随标的走高，同步体现杠杆放大效应。$Corgi U.S. Regional Banks 2x Daily ETF$上涨12.03%。$Corgi META 2x Daily ETF$上涨12.00%。$AOT Software Platform ETF$上涨11.96%。美股ETF跌幅Top5$Defiance Daily Target 2X Long MRNA ETF$下跌21.77%。$Leverage Shares 2X Long OPEN Daily ETF$下跌20.38%。$罗素2000指数三倍做空ETF$上涨1.53%。$香港ETF-iShares MSCI$上涨1.37%。$核能指数ETF-Market Vectors$上涨1.23%。债券ETF涨幅Top 5$First Trust Emerging Markets L","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1153585028.USD","LU0096364046.USD","NLR","YGLD","LU0949170426.SGD","LU2720916845.USD","SH","IE00BK4W5L77.USD","LU1242518857.USD","LU2317271919.USD","LU2756315318.SGD","LU0795875086.SGD","BK4587","LU0316494557.USD","MRNX","GDXD","LU0719512351.SGD","LU1551013342.USD","LU0203202063.USD","SPXL","EMTL","IE0004445015.USD","LU1992135399.USD","LU1496350502.SGD","LU1429558221.USD","IE00B7SZLL34.SGD","MVV","LU1119994496.HKD","SPYH","LU1732799900.SGD","IDNA","SG9999014898.SGD","METD","URTY","LU1064131342.USD","LU2087625088.SGD","IE00BJTD4N35.SGD","METU","SGXZ23171101.USD","LU0786609619.USD","OGIG","DULL","EBND.AU","LU1839511570.USD","LU0310799852.SGD","BK4585","PSCM","IE00BQXX3D17.EUR","FCOM","LU2023250504.SGD","BK4606","LU1803068979.SGD","GOLY","LU2420271590.USD","LU2326559502.SGD","LU1366333091.USD","EMLC","XDAT","NUGT","UPRO","LU1116320901.HKD","LU2461242641.AUD","LU1670711040.USD","LU1674673691.USD","LU2168563687.JPY","LU0053666078.USD","BK4551","SG9999018865.SGD","LU2065170008.USD","LU0795875169.SGD","LU0082616367.USD","BAR","LU0661504455.SGD","LU1989764664.SGD","NVOH","VTWO","LU0323591593.USD","LU2237957902.USD","LU1670711123.USD","RWM","BK4568","LU2249611893.SGD","LU0133085943.USD","LU0823421416.USD","IE0034235188.USD","LU0528227936.USD","LU0545039389.USD","LU1642822529.SGD","PFFR","POWR","LU0820562030.AUD","XRT","LU0265550359.USD","UMAC","LU2361044949.HKD","LU0170899867.USD","OIH","LU2543165471.USD","FAAR","LU2896262040.SGD","LU2360107325.USD","LU2272731782.SGD","IE00BWXC8680.SGD","LU0648001328.SGD","IE00B1XK9C88.USD","NULC","LU2552382132.HKD","IE0009356076.USD","LU0348723411.USD","LU1670628061.USD","FBX","LU2602419157.SGD","LU2168564149.EUR","LU1435385759.SGD","LU2247934214.USD","GDX","IE00BZ1G4Q59.USD","LU0444973449.USD","LU0690374615.EUR","EMBD","LU2764263203.CNY","UMDD","LU2168564222.USD","LU1974910355.USD","LU0784385170.HKD","IE00BN29S564.USD","LU1629891620.HKD","LU2456880835.USD","LU1066053197.SGD","GLD","LU0466842654.USD","IE00B19Z9505.USD","LU0724617625.USD","IE0009G5SDU7.USD","IE00BKDWB100.SGD","GDXU","IE00BD6J9T35.USD","LU2746668974.SGD","LU1988902786.USD","LU2213496289.HKD","LU1732800096.USD","LU1059921491.USD","LU0210536198.USD","GB00B4LPDJ14.GBP","LU1301847155.USD","LU2505996681.GBP","BK4077","LU1861559042.SGD","LU0265550946.USD","LU1074936037.SGD","LU1235294995.USD","LU1242518931.SGD","DMAX","LU0070217475.USD","IE0005OL40V9.USD","MADE","LU0109392836.USD","IE00B5949003.HKD","LU0106261372.USD","SOCL","OPEG","USG","IE00BJTD4V19.USD","LU2764262908.HKD","BK4543","BK4501","SPUU","LU0127658192.USD","LEMB","CBRS","LU0308772762.SGD","IE00B19Z3581.USD","LU1815333072.USD","LU0096362180.USD","LU0061475181.USD","CEF","518880","LU2430703095.HKD","LU2065171402.SGD","LU0552385451.USD","PICK","LU2322448957.HKD","LU0689472784.USD","LU0787776722.HKD","SPYU","LU1815336760.USD","OPEN","LU0882574139.USD","EWH","IE00B4JS1V06.HKD","LU2360106780.USD","IE00BZ199S13.USD","LU0823414551.USD","BK4588","IE00BKVL7J92.USD","BK4562","LU2746668461.USD","LU1989764748.USD","LU1868836914.USD","LU2430703251.USD","LU1718418525.SGD","LU1861214812.USD","LU0354030511.USD","SGXZ51526630.SGD","LU0979878070.USD","BK4534","FBL","LU1564329628.SGD","LGHT","LU0788109477.HKD","DRN","DBP","LU0878866978.SGD","GLDY","IE00BK4W5M84.HKD","LU0642271901.SGD","LU1917777945.USD","LU1992135472.HKD","AAAU","EBND","LU1280957306.USD","LU0708995401.HKD","EWZ","ZAP","BK4548","CBRG","BK4507","SPXS","LU1069344957.HKD","LU0070302665.USD","LU0061474705.USD","LU0210528500.USD","LU2458330169.SGD","SG9999015986.USD","LU2106854487.HKD","LU0097036916.USD","GNOM","GRID","LU1066051498.USD","NANR","LU0690374961.EUR","LU1489326972.SGD","UWM","OUNZ","LU0823434740.USD","LU1232071149.USD","HK0000914686.HKD","LU0444971666.USD","LU1674673428.USD","LU0964807845.USD","LU2023250843.SGD","IE000KEQY171.SGD","LU2125154935.USD","GLTR","SDS","LU2237957811.SGD","VOO","IE00BGHQF417.EUR","LU0320765059.SGD","RSPC","LU0267386448.USD","LU2347655073.USD","MRNY","LU1914381329.SGD","BK4079","HK0000304805.HKD","LU2360032135.SGD","LU2236285917.USD","BK7142","LU0912757837.SGD","LU1720051108.HKD","HK0000304797.USD","LU1084165304.USD","LU0345769631.USD","LU1699723380.USD","FBYY","IE00B19Z8X17.USD","159934","SG9999015952.SGD","IE000YTNTUN2.SGD","GBUG","LU1548497426.USD","LU0784383803.USD","LU2430703178.SGD","GB00B4QBRK32.GBP","LU2506951792.HKD","SGXZ31699556.SGD","TWM","IE00B1BXHZ80.USD","LU0823434583.USD","LU0985320562.USD","LU0943347566.SGD","IE00BQXX3F31.USD","BK4533","LU2357305700.SGD","LU0234570918.USD","LU0354030438.USD","LU2242650005.HKD","LU2063271972.USD","LU1791710400.SGD","LU2458330243.SGD","SG9999014906.USD","LU0072462426.USD","LU2065171311.SGD","IE00BJJMRY28.SGD","SGXZ99366536.SGD","LU2404859741.USD","IE00BFSS8Q28.SGD","LU1720051017.SGD","LU2404859667.USD","XLC","LU1201861249.SGD","LU0154236417.USD","LU0203345920.USD","LU0203201768.USD","LU2463028550.USD","LU2417539215.USD","LU0949170772.SGD","LU0784385840.USD","LU1861558580.USD","LU0149725797.USD","SPYQ","LU0820561909.HKD","IE00BMPRXQ63.HKD","LU0208291251.USD","LU0256863811.USD","LU1861219969.SGD","LU0210533765.USD","SG9999018857.SGD","LU0109391861.USD","BTGD","IE00B19Z8W00.USD","XKRE","VELO","LU0353189763.USD","LU1551013425.SGD","LU0823414478.USD","LU1868837300.USD","SHNY","LU1670710661.SGD","IAU","LU1571399168.USD","LU0211327993.USD","LU0433182093.SGD","LU2462591350.SGD","LU0198837287.USD","LU1564329461.SGD","BK4504","PALL","BK4550","LU2322448791.USD","SG9999014880.SGD","SGDM","LU2264538146.SGD","SGOL","BGLD","LU0353189680.USD","FGDL","LU1145028129.USD","GDXY","NVOX","LU0738911758.USD","LU1778281490.HKD","LU2756315664.SGD","XLB","MRNA","DUST","LU0320765489.SGD","LU1670627923.USD","LU0068578508.USD","WDNA","LU0256863902.USD","LU0276348264.USD","SSO","LU2272731600.USD","LU0417517546.SGD","BEGS","GOAU","LU0985489474.SGD","BK4141","LU0726765562.USD","LU2462157665.USD","LU0215105999.USD","LU0211328371.USD","TNA","LU1316542783.SGD","IE00BQXX3C00.GBP","YSPY","LU2294711713.HKD","UMAL","LU0130102774.USD","LU0957808578.USD","LU1564329115.USD","KGLD","SG9999015945.SGD","IE00B3CCJ633.GBP","LU2860962120.EUR","LU0077335932.USD","LU2023250330.USD","DGP","FDN","MIDU","XME","LU0011850046.USD","IE0034235303.USD","LU1366192091.USD","LU2487616109.SGD","LTL","LU0072461881.USD","LU1823568750.SGD","IE00B7KXQ091.USD","LU2552382058.USD","BK4139","LU2764263039.SGD","LU0162691827.USD","HK0000914660.USD","LU1116320737.USD","JNUG","LU2357125470.USD","LU0820561818.USD","BK4603","ELD","LU1868836757.USD","LU1670710588.SGD","LU0784384876.USD","BK4524","LU2552382215.SGD","LU1127390331.HKD","LU2054465674.USD","SMAX","OPEX","LU1267930490.SGD","LU2347655156.SGD","LU0889565833.HKD","LU0157215616.USD","LU1261432733.SGD","BK4532","BK4592","LU2265009873.SGD","LU2097829019.USD","METW","IE00B3SWFQ91.USD","SG9999001077.SGD","IE00BMPRXN33.USD","LU2168564065.EUR","LU1564329032.USD","LU0061474960.USD","SG9999017495.SGD","IE000ITXATA3.USD","BK4535","LU0174119429.USD","LU2361044865.SGD","LU1814569148.SGD","SG9999004303.SGD","159831","META","AOTS","VELL","PHYS","SGDJ","SPDN","LU0006306889.USD","SPY","LU1868837136.USD","SG9999002224.SGD","DIG","LU2133065610.SGD","SPYM","SG9999002232.USD","LU2361045086.USD","BK4157","DXJ","LU2592432038.USD","IE00B775H168.HKD","IE0003U64NQ7.SGD","IGLD","LU0823421333.USD","DBC","LU2505996509.AUD","LU0476273544.USD","IE0004445239.USD","LU0980610538.SGD","LU0672654240.SGD","UGL","LU0225283273.USD","DZZ","IE00B2PGVK34.USD","IVV","LU0345769128.USD","LU1868836591.USD","LU1697837992.HKD","IE00BMPRXR70.SGD","LU1791710582.SGD","LU1852331112.SGD","BK4207","LU0234572021.USD","SAA","LU2250418816.HKD","BK4096","IE00B4YYXB79.USD","LU2065169927.USD","GB00BDT5M118.USD","LU2125154778.USD","UYM","GDXJ","HIBL","BK4561","LU0640476718.USD","LU1267930730.SGD","LU2087621335.USD","IWM","FBY","LU0203347892.USD","LU2381873111.SGD","LU2168564495.EUR","IE00BJJMRX11.SGD","LU0553294199.USD","GLL","IE00BFSS7M15.SGD","GLDM","SG9999014914.USD","RING","SPXU","LU0683600562.USD","LU0080751232.USD","FEMB","LU0957791311.USD","SGXZ81514606.USD","DGZ","IAUI","IE00B19Z3B42.SGD","LU1003077747.HKD","LU2272731865.HKD","IE0002270589.USD","SG9999015978.USD","LU0079474960.USD","TZA","LU1804176565.USD","MMAX","METV","JDST","LU1035775433.USD","LU0314104364.USD","IAUM","CBRX","LU0056508442.USD","ETN","LU1046421795.USD","IE00BJLML261.HKD","IE0001KFT4U8.USD","LU2473716301.USD","IE000W1ABFV2.USD","LU2403377893.USD","VOX","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}